Attribution of nosocomial seeding to long-term care facility COVID-19 outbreaks.


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
25 Oct 2023
Historique:
medline: 23 11 2023
pubmed: 25 10 2023
entrez: 25 10 2023
Statut: epublish

Résumé

Residents of long-term care facilities (LTCFs) were disproportionately affected by the COVID-19 pandemic. We assessed the extent to which hospital-associated infections contributed to COVID-19 LTCF outbreaks in England. We matched addresses of cases between March 2020 and June 2021 to reference databases to identify LTCF residents. Linkage to health service records identified hospital-associated infections, with the number of days spent in hospital before positive specimen date used to classify these as definite or probable. Of 149,129 cases in LTCF residents during the study period, 3,748 (2.5%) were definite or probable hospital-associated and discharged to an LTCF. Overall, 431 (0.3%) were identified as index cases of potentially nosocomial-seeded outbreaks (2.7% (431/15,797) of all identified LTCF outbreaks). These outbreaks involved 4,521 resident cases and 1,335 deaths, representing 3.0% and 3.6% of all cases and deaths in LTCF residents, respectively. The proportion of outbreaks that were potentially nosocomial-seeded peaked in late June 2020, early December 2020, mid-January 2021, and mid-April 2021. Nosocomial seeding contributed to COVID-19 LTCF outbreaks but is unlikely to have accounted for a substantial proportion. The continued identification of such outbreaks after the implementation of preventative policies highlights the challenges of preventing their occurrence.

Identifiants

pubmed: 37876042
doi: 10.1017/S0950268823001565
pii: S0950268823001565
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e191

Auteurs

Joe Flannagan (J)

United Kingdom Health Security Agency, London, UK.

Dimple Y Chudasama (DY)

United Kingdom Health Security Agency, London, UK.

Russell Hope (R)

United Kingdom Health Security Agency, London, UK.

Simon M Collin (SM)

United Kingdom Health Security Agency, London, UK.

Alex Bhattacharya (A)

United Kingdom Health Security Agency, London, UK.

Rachel Merrick (R)

Public Health Wales, Cardiff, UK.

Nurin Abdul Aziz (NA)

United Kingdom Health Security Agency, London, UK.

Susan Hopkins (S)

United Kingdom Health Security Agency, London, UK.

Gavin Dabrera (G)

United Kingdom Health Security Agency, London, UK.

Theresa Lamagni (T)

United Kingdom Health Security Agency, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH